Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel Raynor currently holds 289,003 shares of ANI PHARMACEUTICALS INC (ANIP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Raynor has been a net seller of ANIP stock. They have purchased $0 and sold $17.4M worth of shares.
Daniel Raynor's most recent insider trade was on Mar 19, 2018, when they sold 5,313 shares at $60.62 per share.
Daniel Raynor serves as Executive at ANI PHARMACEUTICALS INC (ANIP). They have executed 33 insider transactions totaling $17.4M over their tenure at the company.
Daniel Raynor holds the position of Executive at ANI PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Daniel Raynor has shown a selling trading pattern, with $0 in total purchases and $17.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel Raynor was on Mar 12, 2015, when they sold $12.6M worth of ANIP shares. This transaction involved 200,000 shares at $63.00 per share.
Daniel Raynor currently owns 289,003 shares of ANI PHARMACEUTICALS INC (ANIP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel Raynor's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel Raynor has 33 Form 4 filings on record as an insider at ANI PHARMACEUTICALS INC.
Set alerts for Daniel Raynor and 40,000+ other insiders.